Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.

52 participants · First posted Apr 27, 2023

Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision

25 participants · First posted Aug 25, 2010

Gene Therapy for Fanconi Anemia, Complementation Group A

5 participants · First posted Jan 30, 2020

PMX-900

MASH(Repair)

CDP LNP-mRNA(Repair)

EXCISION BIOTHERAPEUTICS

United States

Tissue Repair Ltd

Phoenix Tissue Repair, Inc.

United States

FDA Clears Phase 1 Pediatric CNS Cancer Trial for STAR-001 Combination Therapy

Novel Therapies and Biomarkers Reshape Bladder Cancer Treatment Strategies

GNI Group to Acquire Ayumi Pharmaceutical for ¥44.8 Billion, Building a Cross-Pacific Biopharmaceutical Platform